We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and...

We analyze changes in the willingness to substitute from prescribed pharmaceuticals to more affordable generic equivalents in response to the first experience with a substitution. Using Swedish individual-level data of prescribed and dispensed pharmaceuticals, we employ a dynamic event study and...

I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...

I evaluate how the probability of substitution of a prescribed drug in a pharmacy depends on the pharmacists' profits and patients' out of pocket costs. I use Finnish population-wide data covering all prescriptions of three popular antidepressants. I find that one euro increase in the total...

Using individual level-data, the paper uncovers patient and drug characteristics that determine the probability of using the original patented products despite the presence of generic substitutes in the Czech Republic in the period 2009-2013. Our results reveal different behavioral patterns for...

Using individual level-data, the paper uncovers patient and drug characteristics that determine the probability of using the original patented products despite the presence of generic substitutes in the Czech Republic in the period 2009-2013. Our results reveal different behavioral patterns for...